These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167 [TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid syndrome: from pathogenesis to novel immunomodulatory therapies. Comarmond C; Cacoub P Autoimmun Rev; 2013 May; 12(7):752-7. PubMed ID: 23282546 [TBL] [Abstract][Full Text] [Related]
10. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. Holers VM; Girardi G; Mo L; Guthridge JM; Molina H; Pierangeli SS; Espinola R; Xiaowei LE; Mao D; Vialpando CG; Salmon JE J Exp Med; 2002 Jan; 195(2):211-20. PubMed ID: 11805148 [TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid syndrome, "the best prophet of the future". Amengual O; Atsumi T Mod Rheumatol; 2018 May; 28(3):409-416. PubMed ID: 29385876 [TBL] [Abstract][Full Text] [Related]
12. The antiphospholipid syndrome: still an enigma. Chaturvedi S; McCrae KR Hematology Am Soc Hematol Educ Program; 2015; 2015():53-60. PubMed ID: 26637701 [TBL] [Abstract][Full Text] [Related]
13. Cofactor-Independent Antiphospholipid Antibodies: Implications for Pathogenesis, Diagnosis, and Treatment of Antiphospholipid Syndrome. Lackner KJ; Müller-Calleja N Hamostaseologie; 2019 Jun; 39(2):188-194. PubMed ID: 30419590 [TBL] [Abstract][Full Text] [Related]
14. Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells. Pierangeli SS; Harris EN Lupus; 2003; 12(7):539-45. PubMed ID: 12892395 [TBL] [Abstract][Full Text] [Related]
15. Complement and the antiphospholipid syndrome. Lim W Curr Opin Hematol; 2011 Sep; 18(5):361-5. PubMed ID: 21730831 [TBL] [Abstract][Full Text] [Related]
17. What is known about pediatric antiphospholipid syndrome? Meroni PL; Argolini LM; Pontikaki I Expert Rev Hematol; 2016 Oct; 9(10):977-85. PubMed ID: 27615277 [TBL] [Abstract][Full Text] [Related]
18. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome. Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498 [TBL] [Abstract][Full Text] [Related]
19. What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts? Pengo V; Banzato A; Bison E; Bracco A; Denas G; Ruffatti A Semin Thromb Hemost; 2012 Jun; 38(4):322-7. PubMed ID: 22399307 [TBL] [Abstract][Full Text] [Related]
20. The journey of antiphospholipid antibodies from cellular activation to antiphospholipid syndrome. Willis R; Gonzalez EB; Brasier AR Curr Rheumatol Rep; 2015 Mar; 17(3):16. PubMed ID: 25761923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]